Showing 861-870 of 5852 results for "".
Travelers Beware: Infectious Skin Dermatoses
https://practicaldermatology.com/topics/general-topics/travelers-beware-infectious-skin-dermatoses/18691/Theodore Rosen, MD and Natasha Mesinkovska, MD talk to Derm Insider host Neal Bhatia, MD about traveler maladies that affect the skin. Drs. Rosen and Mesinkovska run down diagnostic and treatment pearls for conditions ranging from parasitic infections to bed bug bites to emerging infections. They alNon-invasive “Mega” Laser Combinations: How to Achieve Maximal Results
https://practicaldermatology.com/topics/practice-management/non-invasive-mega-laser-combinations-how-to-achieve-maximal-results/21150/Improved outcomes and shortened downtime are just some of the advantages of multi-modality approaches to the evolving non-invasive aesthetic front.Pipeline Watch: Sizing Up a Promising Phase III IL-17 Biologic
https://practicaldermatology.com/topics/psoriasis/pipeline-watch-sizing-up-a-promising-phase-iii-il-17-biologic/21214/Pipeline Watch is a new Q&A feature appearing periodically in Practical Dermatology® that explores the potential of therapeutic agents currently under investigation. In each edition, we will speak with investigators from manufacturing companies to gain insights about the development and investigRecently Passed Law Clears Way for New Sunscreen Ingredients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/recently-passed-law-clears-way-for-new-sunscreen-ingredients/21232/By forcing the FDA to clear its backlog of sunscreen ingredients pending review, The Sunscreen Innovation Act is a major win for UV protection efforts.Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.Staying Compliant
https://practicaldermatology.com/topics/practice-management/staying-compliant/19081/Jay A. Shorr, BA, MBM-C, CAC I-V and Mara Shorr, BS, CAC II-V of The Best Medical Business Solutions offer straight talk on compliance, suggesting that practice's turn to trusted experts who can focus on staying within the requirements of the law.Preserve the Core; Live Your Aesthetic
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/preserve-the-core-live-your-aesthetic/19083/Heidi Waldorf, MD, FAAD and Steven Dayan, MD, FACS, Co-Chief Medical Editors of Modern Aesthetics®magazine, talk about the importance of staying true to your aesthetic and address the challenges of preserving the core specialties.Seeing the Whole Picture, and When to Say "No"
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/seeing-the-whole-picture-and-when-to-say-no-/19084/You can turn patients down and still thrive. Heidi Waldorf, MD, FAAD and Steven Dayan, MD, FACS, Co-Chief Medical Editors of Modern Aesthetics®magazine, explain why and how you can tell patients "no," and offer tips for directing patients to a more appropriate intervention.Antioxidants and Sunscreens
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-sunscreens--esapeged/19091/Jennifer Linder, MD, FAAD explains the science behind antioxidants in sunscreens and discusses the benefits of using antioxidants along with SPF.Patient Portals
https://practicaldermatology.com/topics/practice-management/patient-portals/19113/Michael J. Sacopulos, JD, Founder and President of Medical Risk Institute (www.medriskinstitute.com), addresses the role, benefits, and potential pitfalls of patient portals.